Search

everythinglearnresearchcommunity

for

Search:↓

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

People who get alopecia areata after age 50 usually have mild symptoms, high chances of hair regrowth, and often have other health conditions.

Baricitinib was effective in treating both early and late onset alopecia areata.

Older age at onset of alopecia areata leads to less severe and shorter episodes, with most patients experiencing significant hair regrowth.

There are two main types of alopecia areata with different severity, and diagnosis is made through clinical examination and trichoscopy, influencing treatment choices.

Alopecia Areata has no cure, treatments are limited, and the condition often recurs, but new therapies like JAK inhibitors show promise.

Most alopecia areata patients in the study were women, aged 15-49, with patchy hair loss and often had other health conditions.

People with alopecia areata often have other health issues like skin diseases, metabolic syndrome, stomach infections, lupus, anemia, thyroid problems, mental health issues, vitamin D deficiency, and hearing and eye problems.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Diagnosing alopecia areata is challenging and requires careful examination and various tests to distinguish it from other hair loss types.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Most people with alopecia areata have nail changes, which are common but don't greatly affect their quality of life.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

These specific gene polymorphisms are not linked to Alopecia Areata in Egyptians.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

New cytokine-targeted therapies show promise for treating alopecia areata.

Higher antigliadin antibody levels are linked to alopecia areata severity.

Alopecia areata is a complex condition causing hair loss, linked to genetics and immune system issues, and may be related to other autoimmune diseases; treatments vary in effectiveness.

People with alopecia areata may also have allergic rhinitis and should be checked for respiratory allergies.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Alopecia areata in elderly people is usually mild and responds well to treatment.

JAK inhibitors can effectively reverse hair loss in people with alopecia areata.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

PRP is an effective and safe treatment for alopecia areata.